Biotime Announces Distribution Ratio For Distribution Of Agex Therapeutics Shares | Latest News RSS feed

Biotime Announces Distribution Ratio For Distribution Of Agex Therapeutics Shares - Latest News


BioTime Announces Distribution Ratio for Distribution of AgeX Therapeutics Shares

ALAMEDA - BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that its Board of Directors has set the distribution ratio for th... read more

BioTime Reports Second Quarter Results and Recent Corporate Accomplishments

BioTime announced the distribution ratio for the upcoming distribution of AgeX. BioTime shareholders will receive one share of AgeX common stock for ... one of its pluripotent cell lines to Goliver Th... read more

BioTime’s Subsidiary OncoCyte Corporation Files Form 10 Registration Statement for Planned Distribution

--(BUSINESS WIRE)--BioTime ... announced that OncoCyte has filed a Form 10 Registration Statement with the Securities and Exchange Commission (“SEC”) in connection with BioTime’s planned distribution ... read more

Looking for another news?


BioTime's (BTX) CEO Adi Mohanty on Q1 2018 Results - Earnings Call Transcript

We also announced ... AgeX common stock based on the number of common shares of BioTime you owned as of the record date. Other than maintaining your ownership of BioTime shares, no further action will ... read more


BioTime Announces Submission of Draft Registration Statement for a Proposed Distribution of Its AgeX Shares

BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, announced that ... relates to the proposed distribution of some or all of BioTime’s shares ... read more

BioTime to Receive $43 Million From Juvenescence

--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced a new strategic alignment between AgeX Therapeutics ... ... read more

BioTime announces record date for the distribution of AgeX Therapeutics shares

BioTime (BTX +2.8%) has set July 31 record date for the distribution of AgeX Therapeutics shares. The final distribution ratio will be determined by the BioTime Board. BioTime expects the distribution ... read more

BioTime Reports Third Quarter Results and Recent Corporate Accomplishments

OncoCyte announced positive results from the Analytical Validation Study of its liquid biopsy lung cancer diagnostic test, DetermaVU™. BioTime Board of Directors approved a distribution of some or all ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us